title: Levosimendan as a treatment for acute renal failure associated with cardiogenic shock after hip fracture.
abstract: Inotropic drugs are part of the treatment of heart failure; however, inotropic treatment has been largely debated due to the increased incidence of adverse effects and increased mortality. Recently levosimendan, an inotropic positive agent, has been proved to be effective in acute heart failure, reducing the mortality and improving cardiac and renal performance. We report the case of a 75-year-old woman with history of heart and renal failure and hip fracture. Levosimendan was used in preoperative preparation as an adjuvant therapy, to improve cardiac and renal function and to allow surgery.
authors.affiliation: Hospital Universitario de La Paz, Servicio de Anestesiologia, Madrid, Spain. Electronic address: fabiolita_jv@hotmail.com.
authors.forename: Fabiola Quinteros
authors.initials: FQ
authors.lastname: Hinojosa
authors.affiliation: Hospital Universitario de La Paz, Servicio de Anestesiologia, Madrid, Spain.
authors.forename: Margarita
authors.initials: M
authors.lastname: Revelo
authors.affiliation: Hospital Universitario de La Paz, Servicio de Anestesiologia, Madrid, Spain.
authors.forename: Alexander
authors.initials: A
authors.lastname: Salazar
authors.affiliation: Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Genaro
authors.initials: G
authors.lastname: Maggi
authors.affiliation: Hospital Universitario de La Paz, Servicio de Anestesiologia, Madrid, Spain.
authors.forename: Renato
authors.initials: R
authors.lastname: Schiraldi
authors.affiliation: Hospital Universitario de La Paz, Servicio de Anestesiologia, Madrid, Spain.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Brogly
authors.affiliation: Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Fernando
authors.initials: F
authors.lastname: Gilsanz
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology; D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005260:Female; D006620:Hip Fractures / Q000150:complications*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D019990:Perioperative Care; D011724:Pyridazines / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000209:etiology*; D000077464:Simendan; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan
keywords: Cardiogenic shock; Choque cardiogênico; Cuidados perioperatórios; Fratura de quadril; Hip fracture; Insuficiência renal; Levosimendan; Levosimendana; Perioperative care; Renal failure